Search
Close this search box.
An EVAR as unique as your patients,
No two patients are alike – the ALTO® abdominal stent graft system
provides a custom seal and conforms to the needs of specialized anatomies.

ALTO featured in “The Role of Adaptive Sealing Technology in Clinical Practice” article.

50%

of AAA patients requiring treatment are not eligible for on-label+ EVAR1-5

+Due to specialized anatomies.

Off-label EVAR is mostly due to:

Short neck length

Small access vessel diameter

Excessive neck angulation

ALTO offers a personalized experience to

meet the individual needs of each patient’s anatomy.

ALTO’s exclusive technology is optimized for specialized anatomies, including tortuous iliacs
and short necks:
7mm neck indication
13F ID delivery system
Highly comformable limbs

You need an EVAR solution

as unique as they are

Featuring Adaptive Sealing Technology­­ –
only on the ALTO abdominal stent graft system.

ALTO's exclusive adaptive sealing technology

creates an effective seal around the vessel wall,

conforming to the patient’s anatomy. This technology eliminates chronic radial force in the seal zone* and results in stable neck diameters out to 5 years1,2
Adaptive with sealing ring conforming to irregular surface, creating a patient specific seal.
Separation of fixation and seal allows you to fixate in healthy tissue and seal closest to renals.
Treat infrarenal neck lengths as short as 7mm and ­<60° juxtarenal angulation without adjunctive devices.
ALTO’s integrated balloon enables time-saving interoperative deployment and optimizes the molding of the sealing ring.
Proprietary crossover lumen allows easy cannulation.
PTFE iliac limbs with helical nitinol architecture provide flexibility and minimal luminal encroachment.
97.2% Freedom from secondary intervention due to graft occlusion at 5 years.^
Made to Conform
Built to Perform

*Seal zone for the ALTO stent graft is defined as a location 7mm down for the lowest renal.
^The ENCORE analysis pools data on file from ENCORE Data File: April 12, 2018.

Where versatility and durability meet

The ENCORE** analysis

a pooled, retrospective analysis of six trials demonstrated
favorable clinical outcomes over five years.

99%

Freedom from AAA-related mortality

99%

Freedom from
conversion

99%

Freedom from
rupture

98%

Freedom from
reintervention for type IA endoleak

90%

Freedom from
device-related reintervention

0 %

Freedom from AAA-related mortality

0 %

Freedom from
conversion

0 %

Freedom from
rupture

0 %

Freedom from
reintervention for type IA endoleak

0 %

Freedom from
device-related reintervention

**The Ovation platform product family includes a series of device iterations using adaptive neck sealing technology such as Ovation, Ovation Prime, Ovation iX, and ALTO. The devices included in the studies used in the ENCORE analysis all include adaptive sealing technology. ALTO was not included in the ENCORE data set. ENCORE includes results from real-world patient population. 3% of patients had neck characteristics beyond the FDA-approved anatomic IFU. Safety and effectiveness of Ovation and ALTO when used outside the IFU have not been established.
The ENCORE analysis pools data on file from March 20, 2019.

Click Image To Zoom-In

Anatomically adaptive, uniquely powerful

ALTO Testimonial Case Examples

highlight the clinical utility including patient demographics, pre-case planning, intra and post-op results.

Experience ALTO today:
Sign up for VR training demo.

Contact Us:

Contact Us